Healthy Clinical Trial
Official title:
Impact of Training Status of Endurance Athletes on Bioavailability of Flavanones
| Verified date | December 2015 |
| Source | University of Glasgow |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | United Kingdom: Research Ethics Committee |
| Study type | Interventional |
Flavonoids are compounds that have been proven to have a beneficial effect on health, such
as reducing the risk of developing cardiovascular disease and, in some cases, cancer. Citrus
juices have a high flavonoid content. However, the absorption of flavonoids into the body is
limited. This study will investigate whether being physically active improves the absorption
of flavonoids.
Endurance trained athletes will be invited to participate. Following screening procedures
(a. Health Screening Questionnaire; b. height and weight measurement for calculation of Body
Mass Index; c. maximal oxygen consumption (VO2max) uptake test, eligible participants will
undertake two experimental tests; one during a period of normal training, the other
immediately following 1 week of detraining.
In the morning of the experimental trial participants will consume 500 mL of orange juice.
Blood samples and urinary fractions will be collected prior (base line) to and for 24 hours
after orange juice consumption. Participants will be asked to follow a special
polyphenol-free diet and record weighed dietary intake for 2 days preceding each trial and
during the day of the experimental trial.
The study aims to:
1. Determine the effects of training status of endurance athletes on bioavailability of
flavanones in endurance trained individuals
2. Determine whether changes in bioavailability of flavanones are related to changes in
biomarkers of inflammation, oxidative stress, plasma lipids and insulin sensitivity.
| Status | Completed |
| Enrollment | 13 |
| Est. completion date | August 2015 |
| Est. primary completion date | August 2015 |
| Accepts healthy volunteers | Accepts Healthy Volunteers |
| Gender | Male |
| Age group | 18 Years and older |
| Eligibility |
Inclusion Criteria: - trained regularly for at least 4 years and typically perform at least 5 hours of endurance training per week (distance runners, triathletes, cyclists) - healthy - normotensive - non-smokers - not taking any drug therapies - VO2 max >50 ml/kg body mass Exclusion Criteria: - history of gastrointestinal disease - vegetarian - unstable food habits - VO2 max < 50 ml/kg body mass |
Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Basic Science
| Country | Name | City | State |
|---|---|---|---|
| United Kingdom | University of Glasgow School of Medicine | Glasgow |
| Lead Sponsor | Collaborator |
|---|---|
| University of Glasgow |
United Kingdom,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | • Plasma pharmacokinetics of naringenin, hesperetin, eriodictyol, isorhamnetin and phenolic acid metabolites | Change in plasma concentrations collected at base line (0 hours) and 0.5,1, 2, 3,4,5,6,7,8, and 24 hours after ingestion of orange juice | 24 hours | No |
| Primary | • Urinary excretion of naringenin, hesperetin, eriodictyol, isorhamnetin and phenolic acid metabolites | Change in concentrations in urinary fraction collected at base line (0 hours) and after ingestion of orange juice (0-5, 5-8, 8-10, 10-24 hours) | 24 hours | No |
| Secondary | Maximal Oxygen Consumption | Maximal Oxygen Consumption (ml/kg/min) measured in trained state by Douglas bag method | 30 minutes | No |
| Secondary | Body weight | Difference in body weight in kilograms between trained and detrained states measured by TANITA scales (TBF-300, Cranlea, UK) | 7 days | No |
| Secondary | Body fatness | Difference in percentage of body fat between trained and detrained states measured by bioelectrical impedance method (TBF-300, TANITA, Cranlea, UK) | 7 days | No |
| Secondary | Dietary Intake | Difference in energy/macronutrient intake between trained and detrained states measured from 7 day weighted food records | 7 days | No |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT06052553 -
A Study of TopSpin360 Training Device
|
N/A | |
| Completed |
NCT05511077 -
Biomarkers of Oat Product Intake: The BiOAT Marker Study
|
N/A | |
| Recruiting |
NCT04632485 -
Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
|
||
| Completed |
NCT05931237 -
Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults
|
N/A | |
| Terminated |
NCT04556032 -
Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women
|
N/A | |
| Completed |
NCT04527718 -
Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers
|
Phase 1 | |
| Completed |
NCT04107441 -
AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects
|
Phase 1 | |
| Completed |
NCT04065295 -
A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225
|
Phase 1 | |
| Completed |
NCT04998695 -
Health Effects of Consuming Olive Pomace Oil
|
N/A | |
| Completed |
NCT01442831 -
Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects
|
Phase 1 | |
| Terminated |
NCT05934942 -
A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood
|
Phase 1 | |
| Recruiting |
NCT05525845 -
Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI
|
N/A | |
| Completed |
NCT05515328 -
A Study in Healthy Men to Test How BI 685509 is Processed in the Body
|
Phase 1 | |
| Completed |
NCT05030857 -
Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects
|
Phase 1 | |
| Completed |
NCT04967157 -
Cognitive Effects of Citicoline on Attention in Healthy Men and Women
|
N/A | |
| Recruiting |
NCT04494269 -
A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls
|
Phase 1 | |
| Recruiting |
NCT04714294 -
Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers
|
Phase 1 | |
| Completed |
NCT04539756 -
Writing Activities and Emotions
|
N/A | |
| Recruiting |
NCT04098510 -
Concentration of MitoQ in Human Skeletal Muscle
|
N/A | |
| Completed |
NCT03308110 -
Bioavailability and Food Effect Study of Two Formulations of PF-06650833
|
Phase 1 |